Type
1.
Stillwaggon E, Sawers L, Rout J, Addiss D, Fox L. Economic costs and benefits of a community-based lymphedema management program for lymphatic filariasis in Odisha State, India. The American journal of tropical medicine and hygiene [Internet]. 2016; Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5062793/pdf/tropmed-95-877.pdf
Type
1.
Budge P, Sognikin E, Akosa A, Mathieu E, Deming M. Accuracy of coverage survey recall following an integrated mass drug administration for lymphatic filariasis, schistosomiasis, and soil-transmitted helminthiasis. PLoS neglected tropical diseases [Internet]. 2016;10(1):e0004358. Available from: http://journals.plos.org/plosntds/article/asset?id=10.1371%2Fjournal.pntd.0004358.PDF
Type
1.
Nujum Z. Coverage and compliance to mass drug administration for lymphatic filariasis elimination in a district of Kerala, India. International health. 2011;3(1):22-6.
Type
1.
Zeldenryk LM. Measuring the impact of lymphatic filariasis: the development of a quality of life tool using mixed methods. [Internet]. Vol. PhD, Public Health, Tropical Medicine and Rehabilitation Sciences. James Cook University; 2014. pp. 1-168. Available from: http://researchonline.jcu.edu.au/31999/1/31999_Zeldenryk_2013_thesis.pdf
Type
1.
Amaechi EC, Ohaeri CC, Ukpai OM, Nwachukwu PC, Ukoha U. Lymphatic filariasis: knowledge, attitude and practices among inhabitants of an irrigation project community, North Central Nigeria. Asian Pacific Journal of Tropical Disease. 2016;6(9).
Type
1.
Mutheneni SR, Upadhyayula SM, Kumaraswamy S, Kadiri MR, Nagalla B. Influence of socioeconomic aspects on lymphatic filariasis: A case-control study in Andhra Pradesh, India. Journal of vector borne diseases. 2016;53(3):272-8.
Type
1.
Kwarteng A Kwame Nkrumah University of Science and Technology, Ahuno ST, Akoto FO. Killing filarial nematode parasites: role of treatment options and host immune response. Infectious diseases of poverty [Internet]. 2016;5(1):86. Available from: http://download.springer.com/static/pdf/692/art%253A10.1186%252Fs40249-016-0183-0.pdf?originUrl=http%3A%2F%2Fidpjournal.biomedcentral.com%2Farticle%2F10.1186%2Fs40249-016-0183-0&token2=exp=1476108188~acl=%2Fstatic%2Fpdf%2F692%2Fart%25253A10.1186%25252Fs40
Type
1.
Tirkey L, Sengupta D, Naskar S, Ghosh S, Hoque N, Goswami M, et al. Assessing coverage and compliance of mass drug administration under Elimination of Lymphatic Filariasis Program in Malda District, West Bengal. Journal of Comprehensive Health [Internet]. 2016;4(2):49-56. Available from: http://www.journalofcomprehensivehealth.co.in/current%20issue/july2016/PDF/orginalarticle3.pdf
Type
1.
Smith E, Mkwanda S, Martindale S, Kelly-Hope L, Stanton M. Lymphatic filariasis morbidity mapping: a comprehensive examination of lymphoedema burden in Chikwawa district, Malawi. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2014;108(12):751-8.
Type
1.
Yimer M, Hailu T, Mulu W, Abera B. Epidemiology of elephantiasis with special emphasis on podoconiosis in Ethiopia: A literature review. Journal of vector borne diseases [Internet]. 2015;52(2):111-5. Available from: http://www.mrcindia.org/journal/issues/522111.pdf